Control of gene expression at the level of translation initiation by Kaufman, Randal J.
Control of gene expression at the level of 
translation initiation 
Randal J Kaufman 
H o w a r d  Hughes Med ica l  Insti tute, A n n  Arbor, USA 
Protein synthesis is controlled at the level of translation initiation. Cells 
rapidly respond to environmental changes by disassembly of polysomes and 
recruitment of specific mRNAs from inactive ribonucleoprotein particles into 
polysomes active in translation. Recent insights have elucidated specific 
protein and RNA sequence interactions that are required to mobilize 
translation of selective mRNAs. The specificity of translational control 
provides a unique target to inhibit synthesis of specific polypeptides to control 
infectious disease as well as to control aberrant cell growth. In addition, 
greater understanding of the factors that limit protein synthesis is enabling the 
design of novel strategies to optimize protein expression and engineer host 
cells for enhanced growth and protein synthesis capacity. 
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Introduction 
The rate of protein synthesis in eukaryotic cells is con- 
trolled by the amount and the translational efficiency of 
the m R N A  and the activity of  the translational machin- 
ery. The amount of  m R N A  is determined from gene 
transcription, m R N A  processing, m R N A  transport to 
the cytoplasm, and the half-life of the mRNA.  The 
translational efficiency is determined by the m R N A  
primary and secondary structure. The activity of  the 
translational machinery is determined by the availabil- 
ity of  ribosomal subunits and of  factors that influence 
initiation and elongation rates. Most translational con- 
trol occurs at the level of  initiation of protein synthesis. 
The rate of initiation is determined primarily by struc- 
ture at the 5' end of the m R N A  and the activity of 
eukaryotic translation initiation factors (elFs). Many elFs 
that control translation initiation influence all cellular 
mRNAs; however, translation of  many mRNAs is reg- 
ulated through specific protein-mRNA interactions. 
Our knowledge of  the mechanism and regulation of  pro- 
tein synthesis in eukaryotic cells has emerged through 
the study of  in vitro systems reconstituted with puri- 
fied cellular components. Even so, our understanding 
of  eukaryotic protein synthesis is poor compared with 
the process in prokaryotes, primarily as a result of  a lack 
of  genetic approaches in eukaryotes. One common ap- 
proach to study translational control in intact eukaryotic 
cells is to perturb the cell and measure alterations in rates 
of  either specific or of general protein synthesis. Differ- 
ent perturbations include stress such as heat shock, mod- 
ulations of  cell growth such as serum deprivation, and 
infection by different viruses. As viruses utilize the host 
cell machinery for viral m R N A  and protein production 
as well as virion assembly, many viruses establish condi- 
tions within the host cell that allow them to dominate 
the cellular translational apparatus. An understanding of 
the mechanisms that viruses utilize to alter host transla- 
tion has provided insights into cellular mechanisms that 
control translation initiation. In addition, the ability to 
increase or reduce the level of initiation factors through 
expression of  wild-type, antisense, or mutant genes al- 
lows dissection of  the mechanisms that regulate transla- 
tion initiation in mammalian cells. The purpose of  this 
review is to summarize very recent findings providing in- 
sight into the control of protein synthesis in mammalian 
cells that have potential impact on biotechnology. 
Translation initiation factors 
Translation is primarily regulated at the step of ribosome 
binding to mKNA. This process requires at least 10 dif- 
ferent initiation factors that have been purified and char- 
acterized in vitro. Fig. 1 depicts the steps that occur to 
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initiate protein synthesis in mammalian cells. The two 
best studied reactions are the eIF2-promoted binding of 
Met-tRNA to 40S ribosomal subunits and the recycling 
of eIF2, and binding of mRNA to ribosomes promoted 
by eIF4A, eIF4B, and elF4F [1,2]. Translation is regu- 
lated in response to environmental stimuli by covalent 
modification, primarily phosphorylation, of  components 
of  the translational machinery [3°]. 
Ternary complex formation and elF-2 recycling 
Polypeptide chain synthesis initiates when a binary com- 
plex of elF-2 and GTP forms and subsequently binds 
Met-tRNA. This ternary complex of elF2, GTP, and 
initiator Met-tRNA binds the 40S ribosomal subunit to 
generate a 43S preinitiation complex. The 43S preini- 
tiation complex then binds the 5' end of the mRNA 
and scans by migration in the 3' direction until the first 
AUG codon in an appropriate context is reached. Next, 
the 60S ribosomal subunit joins the complex in a step 
that requires hydrolysis of GTP bound to elF-2. This 
initiation factor comprises three subunits [ct (36 kDa), [3 
(37 kDa), and ~/(52 kDa)] and is homologous to other 
trimeric GTP-binding proteins. GDP completely pre- 
vents elF-2 from binding Met-tRNA. Thus, for elF-2 
to promote another round of initiation, GDP bound to 
elF2 must be exchanged for GTR This exchange re- 
action requires catalysis by the guanine nucleotide ex- 
change factor or elF-2B, which is a protein complex 
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composed of five subunits (85kDa, 67kDa, 52kDa, 
37kDa, and 27 kDa). The control of the elF-2 re- 
cycling activity is a primary regulatory step in protein 
synthesis and is controlled at one level by the phospho- 
rylation state of the alpha subunit ofelF-2 (elF-2cc) [3"]. 
Kinases that phosphorylate elF-2 
Three protein kinases, which are well characterized, 
phosphorylate a single residue (Ser51) in eIF-2ct [4"]. 
These are the general control of amino acid utiliza- 
tion kinase from Saccharomyces cerevisiae (GCN2), the 
hemin-regulated kinase from reticulocyte lysate (HRI), 
and the double-stranded RNA-activated protein kinase 
(PKR or DAI). Phosphorylation ofeIF-2(~ stabilizes the 
eIF2-GDP-eIF2B complex and consequently prevents 
GTP exchange, eIF2 recycling, and further initiation 
events. It is proposed that translation arrest results from 
sequestration of eIF-2B by phosphorylated eIF-2. Small 
changes in the phosphorylation status of eIF-2 can dra- 
maticaUy effect protein synthesis because the concentra- 
tion of eIF-2B in the cell is approximately an order of 
magnitude less than that of eIF-2. 
The eIF-20t kinases can regulate both global as well as 
specific mRNA translation. The best studied example 
of control of specific mRNA translation occurs in S. 
cerevisaie, where amino acid starvation activates GCN2 
kinase to phosphorylate eIF-2(1 [5°°]. This specifically 
stimulates GCN4 mRNA translation through the ability 
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Fig. 1. Initiation of protein synthesis. The two major control steps in translation initiation are depicted. In the first step, the ternary complex 
(elF-2-GTP-Met-tRNA) promotes binding of the 40S ribosomal subunit to the mRNA. In the second step, eIF-4A, elF-4B, and elF-4F promote 
unwinding of secondary structure at the 5' end of the mRNA. The elF-2 cycle is depicted, showing the exchange of GTP (diamond) with 
GDP (inverted triangle) that is required to continue initiation events. The points where initiation factors elF-2 (2), elF-3 (3), and elF-5A (4C) 
act are also shown. 
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to scan through open reading frames (ORFs) upstreain 
of  GC N4  and allows initiation at the GCN4 AUG 
initiation codon. The presence of  the upstream ORFs 
is required to mediate GCN2 translational control of  
GCN4. Analogous examples of  this type of  m R N A -  
specific control mediated by e lF-2a phosphorylation 
are likely to occur in higher eukaryotic cells. Two ex- 
amples have been described where mRNAs both con- 
tain cis-acting elements that mediate PKR activation in 
a localized manner and inhibit translation where gen- 
eral m R N A  translation is not affected. The $1 gene 
from reovirus is not translated in the absence of  the 
sigma 3 gene product, whereas other mRNAs are ef- 
ficiently translated [6"]. In addition, plasmid-derived 
mRNAs are inefficiently translated in DNA transfec- 
tion experiments [7"*]. It is proposed that this selective 
translational repression is mediated through PKR activa- 
tion and phosphorylation o f  elF-2 in the vicinity of  the 
m R N A  [7"']. 
Expression of  non-functional PKR mutants perturbs cell 
growth and transforms NIH  3T3 cells [8,9]. This ob- 
servation has generated interest in the role of  PKR 
activation in translational control and in other cellular 
processes that may control cell growth. A minimum 
of  50bp duplex o f  double-stranded RNA can acti- 
vate PKR, in addition to a variety of  more complex 
R N A  structures [10,11]. Double-stranded R N A  inter- 
acts with two conserved double-stranded RNA-binding 
domains in the amino terminus and probably promotes 
dimerization of  the kinase to elicit autophosphoryla- 
tion [12]. The phosphorylated kinase is constitutively 
active, no longer requires double-stranded R N A  for 
activity, and can utilize elF-20~ as a substrate. In mam- 
malian cells, transcription of  PKR is induced as part of  
the cellular antiviral response to interferon. Interferon- 
resistant viruses have evolved specific gene products that 
inhibit activation o f  PKR. These include the R N A  poly- 
merase III transcripts VA R N A  and EBER R N A  from 
adenovirus and Epstein-Barr virus, respectively [13], the 
E3L and K3L gene products from vaccinia virus [14], and 
the sigma 3 gene product from reovirus [15]. These gene 
products either directly bind PKR and inhibit its activity 
(e.g. the R N A  polymerase III gene products and K3L) 
or compete with PKR to bind double-stranded RNA,  
thus preventing activation (e.g. E3L and the sigma 3 
gene products). Recently, two cellular gene products, the 
human immunodeficiency virus (HIV) R N A  target se- 
quence (TAR)-binding protein (TRBP) [7"] and a pro- 
tein activated upon influenza virus infection (p58)[16], 
have been shown to inhibit the activity of  PKR. Over- 
expression of  p58 transforms NIH3T3 cells, implicating 
its importance in growth control [17"]. As it is unlikely 
that these cellular gene products are solely responsible 
for down-regulation of  PKR upon viral infection, fu- 
ture studies are required to elucidate how these cellular 
gene products regulate PKR activity, which in turn, reg- 
ulates cellular m R N A  translation. 
The observed tumor-suppressing activity of  PKR may 
explain the anti-proliferative effects of  interferon. At 
present, it is not known if the observed tumor-suppress- 
ing activity of  PKR is mediated by elF-2ct phospho- 
rylation to inhibit translation or whether PKR phos- 
phorylates another substrate involved in growth con- 
trol. Recent  experiments indicate that PKR can acti- 
vate the transcription factor NF-rd3, possibly through 
phosphorylation of its inhibitor, IKB [18,19"°]. In ad- 
dition, double-stranded R N A  can activate NF-rd3 re- 
sponsive genes (i.e. those encoding intercellular adhe- 
sion molecule 1, vascular cell adhesion molecule 1, and 
E-selectin) in endothelial cells, through a mechanism 
that likely requires PKR activation [20]. It is interest- 
ing that PKR is also activated upon calcium mobiliza- 
tion induced by ionophore treatment (SR Srivastava, RJ 
Kaufman, unpublished data), suggesting that PKR may 
participate in a more general growth factor signal trans- 
duction pathway, as previously suggested [21,22]. 
Control of elF-2cc phosphorylation by stress conditions 
Inhibition of  protein synthesis correlates with elF-2~ 
phosphorylation in response to a wide variety of  dif- 
ferent stimuli, including heat shock, serum deprivation, 
glucose starvation, amino acid starvation, exposure to 
heavy metal ions, and other inducers of  the stress re- 
sponse, and upon viral infection and plasmid DNA 
transfection [3"]. The importance of  this modification in 
translational control was demonstrated by expression of  
a Ser51--+Ala mutant ofelF-20~ that cannot be phospho- 
rylated. In cells that express this mutant, protein synthesis 
is not inhibited upon activation o f  PKR following viral 
infection or DNA transfection [7"]. In addition, expres- 
sion of  this mutant protects cells from both inhibition of  
protein synthesis and reduction in elF-2B activity upon 
heat-shock treatment [23,24"] This is the strongest ev- 
idence that elF-2ct phosphorylation reduces functional 
elF-2B activity in vivo. Regulation of  elF-2{* activity 
may also occur through regulation of  dephosphoryla- 
tion, but the phosphoprotein phosphatase(s) involved 
have not yet been characterized in detail. An elF-2- 
associated protein of  67kDa that can protect elF-2tx 
from HRI-mediated phosphorylation has been isolated 
from reticulocyte lysate and the gene recently cloned 
[25]. This unusual protein contains multiple O-linked 
N-acetylglucosamine residues that are required to pro- 
tect elF-2t* from phosphorylation. An understanding 
of  the mechanisms that regulate phosphorylation and 
dephosphorylation of  elF-20t will help elucidate how 
phosphorylation of  elF-2ct mediates control of  transla- 
tion. 
Upon heme deprivation in reticulocyte lysates, HR I  
is activated from a latent to an active form by au- 
tophosphorylation. Heroin promotes intersubunit disul- 
fide bond formation in both latent and activated phos- 
phorylated HRI.  Recent studies have shown that HR I  
is in a complex with the cellular heat-shock proteins of  
70 kDa (hsp70) and 90 kDa (hsp90) in an inactive form in 
hemin-supplemented lysates, and dissociates from hsp70 
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upon activation [26"]. Pretreatment of  cells with heat 
induces hsp70 and hsp90 expression and abrogates the 
inhibitory effect o f  subsequent heat shock on protein 
synthesis, suggesting that heat-shock proteins may also 
play a role in the activation of  the elF-2ct kinase that 
occurs in response to heat shock. Although the eiF- 
2ct kinase that is activated upon heat shock has not yet 
been identified, results suggest that denatured proteins 
bind and sequester heat-shock proteins, such as hsp70, 
and lead to activation of  an HRI-like kinase in response 
to heat shock. 
Factors that promote mRNA unwinding and 
ribosome binding to mRNA 
In contrast to initiation in prokaryotes, ATP is required 
for translation initiation in eukaryotes. The best un- 
derstood function for the 5' m7G cap structure is its 
ability to promote 40S ribosomal subunit binding to 
mRN A  in an ATP-dependent manner. A cap-binding 
protein complex, elF-4F, which comprises three subunits 
(elF4Ct, elF-4~, and elF-4T), functions to 'melt' RNA  
secondary structure within the 5' end of  the mRNA in 
an ATP-dependent manner. The integrity of  this com- 
plex is required to promote cap-dependent translation 
initiation, and recent studies suggest this complex may 
also promote cap-independent translation initiation [27]. 
Intriguingly, recent observations suggest this complex is 
also involved in coupling translation initiation at the 5' 
end of the m R N A  with polyadenylation at the 3' end 
of  the mRNA. 
The small cap-binding protein, elF-4E 
Eukaryotic initiation factor 4E is a monomeric cellular 
protein that also exists as the elF-4ct subunit of  eiF- 
4E It is a 24kDa protein that binds directly to the 
5' m7G cap structure in an ATP-independent man- 
ner, and evidence has accumulated that the activity 
of  this factor plays a crucial role in cell growth and 
differentiation. It is thought that elF-4E is probably 
the first factor to interact with an m R N A  to initi- 
ate translation. Over-expression of  elF-4E transformed 
NIH 3T3 cells, deregulated growth in HeLa cells, and 
cooperated with nuclear oncoproteins, such as v-myc, to 
transform rat primary embryo fibroblasts [28]. Over-ex- 
pression of  elF-4E activated ras and over-expression of  
GAP, the negative effector of  ras, caused reversion of  the 
elF-4E-mediated transformed phenotype [29]. Reduc- 
tion of  elF-4E levels caused a reversal of  ras-mediated 
transformation and a general inhibition of  protein syn- 
thesis with an increase in translation of  mRNAs encod- 
ing heat-shock proteins [30,31]. Finally, over-expression 
of  elF-4E induced mesoderm formation in Xenopus 
laevis embryos [32°']. These observations suggest that 
elF-4E is an early downstream target of  growth stim- 
ulatory molecules [e.g. platelet-derived growth factor 
(PDGF), epidermal growth factor, tumor necrosis fac- 
tor, insulin, etc]. 
The activity of  elF-4E is increased by phosphorylation 
that occurs upon increased protein synthesis in response 
to growth factor stimulation [3"]. Dephosphorylation 
of  elF-4E correlates with inhibition of  cellular protein 
synthesis in response to heat shock and viral infection. 
Although initial studies suggested Ser53 as a phosphory- 
lation site, this residue has not been confirmed as the 
primary site in subsequent studies ([33]; RE  Rhoads, 
personal communication). Recently, two elF-4E binding 
proteins (elF-4E BPs) have been cloned and shown to 
negatively regulate elF-4E activity and inhibit translation 
of  cap-dependent mRNAs, but not translation from in- 
ternal ribosome entry site (IRES) (see below) sequences 
(G Belsham, N Sonenberg, personal communication). 
Insulin-mediated stimulation of  protein synthesis was 
associated with phosphorylation of  the elF-4E BP and 
dissociation of  elF-4E BP from elF-4E. Future studies 
should elucidate how the activity of  elF-4E is regulated 
in vivo. 
The large cap-binding protein complex, elF-4F 
Eukaryotic initiation factor 4F is a heterotrimer of  eiF- 
4ct, elF-4[~ (elF-4A), a protein that has ATPase and 
R N A  helicase activity, and elF-4~' (p220). The pri- 
mary role identified for elF-4F appears to be its abil- 
ity to 'melt' secondary structure of m R N A  in an ATP- 
dependent manner. The cloning and mutational analy- 
sis of  elF-4A demonstrated that this factor is a member 
of  a gene family that exhibits ATP-dependent hehcase 
activities, which are critical for cap-dependent and cap- 
indepenent translation [34]. This family of  related AT- 
Pases contains the consensus sequence motif  DEAD 
box that is present in a special version of  the B mo- 
tif of  ATP-binding proteins [35]. The helicase activity 
of  elF-4A is more effective as part of  elF-4F and is 
stimulated by the presence of  elF-4B, an RNA-binding 
protein. Eukaryotic initiation factor 4B exhibits a highly 
variable degree of  serine phosphorylation that correlates 
with initiation activity. It is dephosphorylated in response 
to heat shock and becomes phosphorylated after addition 
of  serum [1,3"]. 
Although the role of  elF-4~' (p220) in translation initia- 
tion is unknown, its importance is suggested from picor- 
naviral infection where proteases induce p220 cleavage 
and inactivation that roughly coincides with inhibition 
of  host protein synthesis [36]. Even so, recent results sug- 
gest that cleavage of  p220 is not directly responsible for 
the shutoffin host m RN A  translation [36,37]. Recently, 
the cDNA clone encoding elF-4~' has been isolated, and 
viral-induced cleavage sites were identified that should 
provide the basis for experiments to directly test the role 
of  p220 cleavage in protein synthesis [38]. 
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m R N A  
structural requirements 
Although the precise mechanism by which eukaryotic 
ribosomes initiate at appropriate AUG codons within 
m R N A  involves numerous components and is regulated 
by many steps, a substantial amount of  evidence supports 
a scanning model for translation initiation [39,40]. This 
model proposes that a 40S ribosomal subunit binds to 
the 5' end of  the mRNA and migrates in the 3' direc- 
tion until it encounters the first AUG triplet which, if 
present in an appropriate context, can efficiently serve as 
the initiator codon. Comparison o f  the sequence context 
o f  the initiation codon within eukaryotic mRNAs has 
demonstrated that the most favored initiation site has the 
following consensus sequence: 5 ' - C C A / G C C A  UGG-3'  
(where the initiation codon is italicized) [39]. 
O f  paramount importance is the purine in the -3 po- 
sition and secondarily, the guanine in the +4 position. 
Even so, it is now appreciated that many viral and cellu- 
lar mRNAs have specific sequence and secondary struc- 
tural elements promoting internal ribosome binding that 
is independent of  the 5' cap structure. 
The 5' untranslated region and cap structure 
The primary determinants for the efficiency by which 
ribosomes bind m R N A  and initiate polypeptide chain 
synthesis are the structural features within the 5' non- 
coding region of  the mRNA. In addition to the 5' cap 
structure, eukaryotic mRNAs possess a 5' non-coding 
region of  variable length preceding the initiator methio- 
nine codon. The primary sequence and secondary struc- 
ture within this region can greatly influence translational 
efficiency. Most long 5' untranslated regions contain one 
or more AUG codons followed shortly by in-frame ter- 
mination codons. Although little evidence suggests that 
these small ORFs have general biological significance, 
examples have been found where the small polypep- 
tides are translated from several viral mRNAs and where 
mutations within these ORFs can alter initiation at the 
primary downstream AUG within that m R N A  (see [41] 
and references therein). Experimental evidence has ac- 
cumulated that increased secondary structure within the 
5' untranslated region of  the m R N A  results in reduced 
translational efficiency [39]. Increased suppressive effects 
on translation occur when the structure is positioned 
close to the 5' cap, and more stable hairpin structures 
are required to inhibit downstream translation when 
their distance from the 5' cap is increased. A -60 kCal 
structure can cause a 40S ribosome to pause immediately 
upstream of  the structure, providing strong supporting 
evidence for the scanning model of  translation initiation. 
Cellular mRNAs that have long 5' untranslated regions 
with potential to form secondary structures and dramati- 
cally influence translation include collagen, c-Abl, c-Jun 
, c-Myc, and PDGF A chain. The transforming activity 
ofe lF-4E may result from increased translation initiation 
of  this class of  mRNAs. 
Specific structures within mRNA that mediate selective 
translational control 
The best studied example o f  a 5' untranslated region that 
regulates translation initiation in higher cells is that of  
ferritin biosynthesis controlled by iron (see recent re- 
view [42"']). Two proteins responsible for the uptake 
and detoxification of  iron in higher eukaryotic cells 
are the transferrin receptor and ferritin, respectively. 
The expression of  both these proteins is regulated by 
iron. Whereas ferritin synthesis is inhibited in response 
to iron deprivation, the synthesis of  the transferrin re- 
ceptor increases. The reduction in ferritin synthesis is 
mediated at the level of  translation initiation, whereas 
the increase in transferrin receptor is mediated through 
increased m R N A  stability. A 30 bp R N A  sequence ele- 
ment is necessary and sufficient for the ferritin m R N A  
to be translationally controlled by iron. This iron- 
responsive element (IRE) located in the 5' end of  the 
ferritin m R N A  forms a stable stem-loop structure that 
is required for iron-mediated translational regulation. A 
90 kDa IRE-binding protein (IKE-BP) both specifically 
binds the IRE in the 5' end of  the ferritin m RNA and 
acts as a translational repressor. IRE-BP exists in two 
conformations, depending on the oxidation-reduction 
potential. In the absence of  iron, two sulflaydryls within 
the protein are free, and this conformation exposes a 
high-affinity IRE-binding site (Kd=20 pM). When iron 
is abundant, these sulfhydryls form a disulfide bond that 
reduces the IRE-binding site affinity to 3 nM and per- 
mits translation of  the ferritin mRNA. This 'sulflaydryl- 
switch' may constitute a general mechanim by which 
protein-nucleic acid interactions are regulated. The iron- 
induced translational stimulation was used in combina- 
tion with a metallothionein-inducible promoter to en- 
gineer cells for a 500-fold induction of  gene products 
derived from specifically desired mRNAs [43]. 
Another example of  selective m R N A  translational con- 
trol mediated by specific m RN A  sequences is that 
of  the ribosomal proteins and elongation factors, such 
as eukaryotic elongation factor let. This family of  
transcripts contains mRNAs with a polypyrimidine tract 
immediately a~er their 5' cap structure. These mRNAs 
are selectively translated upon phosphorylation of  the 
40S ribosomal protein $6. $6 is phosphorylated upon 
activation of  p70s6k/p85 s6k. The immunosuppressant 
rapamycin blocks activation of  p70s6k/p85 s6k, reduces 
phosphorylation of  $6, and selectively blocks transla- 
tion of  the polypyrimidine tract containing mRNAs 
[44"°]. These findings provide a plausible mechanism for 
rapamycin inhibition o f  mitogen induction o f  T cells 
entering S phase. It will be interesting to find out 
whether similar immunosuppressant effects may be ob- 
tained through the use of  anti-sense oligonucletides di- 
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rected toward the polypyrimidine tract on these selective 
mR.NAs. 
The internal ribosome entry site 
Many reports describing mRNAs that can be translated 
in a cap-independent manner in mammalian cells have 
now appeared [37,45]. The best studied examples are 
pic0rnavirus mRNAs that have an extremely long 5' 
untranslated region (650-1300 bases) containing mul- 
tiple upstream AUG codons. The mechanism for cap- 
independent translation of  picornaviral mRNA (e.g. 
poliovirus and encephalomyelocarditis virus) occurs by 
internal binding of  ribosomes within the 5' untrans- 
lated region of  the m R N A  without scanning from 
the 5' end. Although specific proteins that bind these 
IRES sequences have been identified (e.g. elF-2, the 
polypyrimidine tract binding protein p57 [46], or the La 
autoantigen p52 [47]), their significance in internal initi- 
ation is presently unknown. The IRES provides efficient 
translation of an adjacent downstream coding region, re- 
gardless of  its position within the mRNA. Technological 
advances in expression technology derived from use of  
the IRES to express dicistronic mRNAs [48]. The IRES 
upstream from a selectable marker coding region was also 
used to select for homologous recombination in mam- 
malian cells [49]. 
A number of cellular mRNAs that utilize internal ribo- 
some binding include the imnmnoglobulin-binding pro- 
tein BiP [50], Antennapedia [51], and fibroblast growth 
factor (FGF)-2 [52"]. FGF-2 (basic FGF) is particularly 
interesting because three CUG initiation codons occur 
upstream of the classical AUG initiation codon. Initiation 
from one of these CUG codons results in a nuclear- 
localized form of  FGF that immortalizes cells, whereas 
initiation at the classical AUG codon results in a cyto- 
plasmic form of  FGF-2 that transforms cells [53",54]. A 
100kDa protein that binds the 5' untranscribed region 
(UTR) was identified and its presence in different cell 
types coincides with utilization of the CUG codon and 
the transformed phenotype [52°]. 
The role of the 3' poly(A) tail in translation 
initiation 
Most eukaryotic mR.NAs have a polyadenylic acid 
[poly(A)] tract at their 3' termini. These poly(A) tails 
are added post-transcriptionally in the nucleus with an 
initial length of  200-250 adenylate residues. Following 
transport to the cytoplasm, the poly(A) tail is shortened 
to a steady-state length of  50-70 adenylate residues. The 
poly(A)-binding protein (PABP) is required for poly(A) 
shortening and for joining of  the 60S ribosomal subunit. 
Increasing evidence suggests that the poly(A) tail plays 
a key role in translation initiation at the 5' end of  the 
m R N A  [55,56]. In the absence ofpoly(A), mRNAs are 
recruited into the 80S initiation complex at a reduced 
efficiency. Translation of m R N A  is inhibited upon ad- 
dition of  excess poly(A) to in vitro translation reactions 
and may may result from competition for a limiting fac- 
tor that binds both the 5' cap structure and the poly(A) 
tail, possibly elF-4F and elF-4B [57"]. Poly(A) may bind 
and induce a conformational change in a factor required 
for translation. Cloning of the poly(A)-binding protein 
(PABP) and genetic disruption in S. cerevisiae demon- 
strated that PABP facilitates 80S initiation complex 
formation and is required for poly(A) tail shortening. 
Upon selection for reversion, independent extragenic 
suppressor mutants were identified that allow translation 
initiation without significantly affecting the poly(A) tail 
shortening defect. These suppressor mutations result in 
an increase in the amount of  the 60S ribosomal subunic 
Conclusions 
As the mechanisms that control mRNA recruitment 
onto polysomes become clear, it will be possible to engi- 
neer cells to produce high levels of specific polypeptides 
at desired times. The ability to control the utilization of  
any particular mRNA in a host cell that is producing 
a particular protein product should allow optimization 
of  the expression level and growth properties of  the cell 
to maximize product yield. Understanding how specific 
mRNAs are chosen for translation initiation will provide 
avenues to intervene in very selective ways to prohibit 
synthesis of  specific polypeptides, such as oncogenes 
or viral polypeptides, and to eventually design specific 
agents to prevent infectious disease and cancer. 
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